Author:
Cao Zhi,Wei Xiujian,Xing Shuming,Zhang Jiahao,Wang Shuqi,Yue Lingfeng,Zhang Jiahe,Jiang Nan,Zhai Xin
Funder
Liaoning Revitalization Talents Program
Reference31 articles.
1. Unraveling the cross-talk between N6-methyladenosine modification and non-coding RNAs in breast cancer: Mechanisms and clinical implications;Xuan;Int. J. Cancer,2024
2. Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer;Li;Biomed. Pharmacother.,2023
3. Recent advances in therapeutic strategies for triple-negative breast cancer;Yun;J. Hematol.,2022
4. Translational adaptation in breast cancer metastasis and emerging therapeutic opportunities;Siyu;Trends Pharmacol. Sci.,2024
5. Glutamine transporter SLC38A3 promotes breast cancer metastasis via Gsk3β/β-catenin/EMT pathway;Zheqiong;Cancer Lett.,2024